News
Small Cap Stock news
-
ABVC BioPharma Announces Fiscal Year 2022 Financial and Operational Results
[ad_1] Fremont, CA – (NewMediaWire) – March 31, 2023 – ABVC BioPharma, Inc. (Nasdaq: ABVC), a biotechnology company specializing in…
Read More » -
Museum Hits the Number Two Destination Spot for Burbank
[ad_1] (NewMediaWire) – April 01, 2023 – Burbank, CA – Despite being surrounded by the biggest movie studios in the…
Read More » -
Address Thinning Hair or Bald Spots with Regenerative Hair Loss Treatments at QC Kinetix (Colchester)
[ad_1] Colchester, VT – (NewMediaWire) – March 31, 2023 – via QC Kinetix —Hair loss has many causes, from stress…
Read More » -
NewMediaWire | QC Kinetix (Exton)
[ad_1] Exton, PA – (NewMediaWire) – March 31, 2023 – via QC Kinetix — Although painless, dealing with thinning hair…
Read More » -
QC Kinetix (Sylvania) Offers Regenerative Sports Medicine Solutions in Toledo, OH
[ad_1] Toledo, OH – (NewMediaWire) – March 31, 2023 – via QC Kinetix — Athletes search for a sports medicine…
Read More » -
Splash Beverage Group Reports 2022 Fourth Quarter and Full Year Financial Results
[ad_1] Fort Lauderdale, FL – (NewMediaWire) – March 31, 2023 – Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the…
Read More » -
Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer’s Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer’s and Parkinson’s Disease and Related Neurological Disorders Conference in Sweden
Tiziana Life Sciences Ltd. (Nasdaq: TLSA) a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today…
Read More » -
LiveOne’s Buyback Exceeds 2,245,000 Shares
[ad_1] – Leaving Capacity to Repurchase an Additional $1,700,000 Worth of Stock – Los Angeles, CA – (NewMediaWire) –…
Read More » -
BitFrontier Releases Quarterly Progress Report to Investors
[ad_1] San Jose, CA – (NewMediaWire) – March 30, 2023 – BitFrontier Capital Holdings Inc (OTCMKTS: BFCH), a leading provider…
Read More » -
GeoVax to Participate at the World Vaccine Congress with Multiple Presentations
[ad_1] New data from the ongoing Phase 2 trial of GEO-CM04S1 to be presented Atlanta, GA – (NewMediaWire) –…
Read More »
